BEAM vs CDW · rev $63.5M vs P/E 22, rev $21.00B
Beam Therapeutics Inc (BEAM) versus CDW Corp (CDW) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
CDW Corp (CDW) is a information technology services company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported CDW revenue for 2024-12-31 was $21.00B. Net income was $1.08B. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
BEAM currently screens at market cap $2.01B. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
Not investment advice. Open the BEAM and CDW stock pages for the full models.
Not investment advice.